Stroke AHA/ASA/X
Jun 26, 2025, 13:17
AI and STROKE: Evidence on Software Performance in a Real-world Setting
Stroke AHA/ASA Journal recently posted on X:
”STROKE: This topical review by Aziz et al. on automated vessel occlusion software discusses emerging evidence of their utility, underlying algorithms, real-world diagnostic performance, and limitations | AHAJournals”
Read the full article here.
AI‑Powered Stroke Assessment – sounds promising, right?
But aren’t you surprised by the lack of data on how the software actually works, who is using it, and where the evidence of its utility in a real‑world setting is?
Here come Yasmin N. Aziz, Department of Neurology and Rehabilitation Medicine, University of Cincinnati, et al. to clear the dust from your eyes with a brilliant educational review of automated vessel occlusion software.
More updates on the use of AI and deep learning in medicine are coming in Hemostasis Today.
-
Mar 11, 2026, 18:27Cesar Garrido and Lackram Bodoe Are Advancing WFH Partnerships in Trinidad and Tobago
-
Mar 11, 2026, 18:14Aloke Finn: Silent Plaque Rupture and Healing in Coronary Artery Disease
-
Mar 11, 2026, 17:23Mattia Galli: A Privilege to Collaborate on Such a Complex Topic as Cardio-Rheumatology
-
Mar 11, 2026, 17:12Shubham Misra: Proteomic Biomarkers for Acute Stroke Subtype Classification
-
Mar 11, 2026, 16:55Melanie Daniel: Modeling High-Purity von Willebrand Factor for Individualized Dosing in Surgery
-
Mar 11, 2026, 15:46Bleeding and Thrombosis Outcomes in Older Patients With Myelodysplastic Syndromes – JTH
-
Mar 11, 2026, 15:37Sonia Muliyil: The Greatest Benefit is The Wellbeing and Sustenance of Half The World’s Population
-
Mar 11, 2026, 15:34Kymentie Ferdinande: Rivaroxaban in Cirrhosis and the Path Toward Individualized Anticoagulation
-
Mar 11, 2026, 15:34Sheharyar Raza: When More Testing Isn’t Always Better in Healthy Donor Screening